Gain Therapeutics plans Phase 2 Rexaceract trial in Q1 next year

Gain Therapeutics said it plans to initiate a Phase 2 trial of Rexaceract in the first quarter of next year, according to a company announcement.

Detected & updated continuously · Source: Nebula